User profiles for Rita Loudermilk
 | Rita P LoudermilkGraduate student, UCSF Verified email at ucsf.edu Cited by 1376 |
[HTML][HTML] Evaluation of SARS-CoV-2 serology assays reveals a range of test performance
…, J Levan, L Torres, LA Farrington, RP Loudermilk… - Nature …, 2020 - nature.com
Appropriate use and interpretation of serological tests for assessments of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure, infection and potential immunity …
respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure, infection and potential immunity …
[HTML][HTML] Global absence and targeting of protective immune states in severe COVID-19
Although infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
pleiotropic and systemic effects in some individuals 1 , 2 – 3 , many others experience …
pleiotropic and systemic effects in some individuals 1 , 2 – 3 , many others experience …
[HTML][HTML] Test performance evaluation of SARS-CoV-2 serological assays
…, L Torres, LA Farrington, R Loudermilk… - Nature …, 2020 - ncbi.nlm.nih.gov
Appropriate use and interpretation of serological tests for assessments of SARS-CoV-2
exposure, infection and potential immunity require accurate assay performance data. We …
exposure, infection and potential immunity require accurate assay performance data. We …
[PDF][PDF] Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms
Individuals with coronavirus disease 2019 (COVID-19) frequently develop neurological
symptoms, but the biological underpinnings of these phenomena are unknown. Through single-…
symptoms, but the biological underpinnings of these phenomena are unknown. Through single-…
[HTML][HTML] Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine–induced antibody and T cell immunity and function
…, R Dandekar, BD Alvarenga, RP Loudermilk… - JCI insight, 2022 - ncbi.nlm.nih.gov
BACKGROUND Vaccine-elicited adaptive immunity is a prerequisite for control of SARS-CoV-2
infection. Multiple sclerosis (MS) disease-modifying therapies (DMTs) differentially target …
infection. Multiple sclerosis (MS) disease-modifying therapies (DMTs) differentially target …
A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis
…, R Dandekar, R Loudermilk… - Proceedings of the …, 2020 - National Acad Sciences
Central nervous system B cells have several potential roles in multiple sclerosis (MS):
secretors of proinflammatory cytokines and chemokines, presenters of autoantigens to T cells, …
secretors of proinflammatory cytokines and chemokines, presenters of autoantigens to T cells, …
[PDF][PDF] ReScan, a multiplex diagnostic pipeline, pans human sera for SARS-CoV-2 antigens
Comprehensive understanding of the serological response to SARS-CoV-2 infection is important
for both pathophysiologic insight and diagnostic development. Here, we generate a pan…
for both pathophysiologic insight and diagnostic development. Here, we generate a pan…
Anti–SARS-CoV-2 and autoantibody profiles in the cerebrospinal fluid of 3 teenaged patients with COVID-19 and subacute neuropsychiatric symptoms
…, C Johns, TT Ngo, R Dandekar, RL Loudermilk… - JAMA …, 2021 - jamanetwork.com
Importance Neuropsychiatric manifestations of COVID-19 have been reported in the
pediatric population. Objective To determine whether anti–SARS-CoV-2 and autoreactive …
pediatric population. Objective To determine whether anti–SARS-CoV-2 and autoreactive …
Competitive SARS-CoV-2 serology reveals most antibodies targeting the spike receptor-binding domain compete for ACE2 binding
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread
around the world, there is an urgent need for new assay formats to characterize the humoral …
around the world, there is an urgent need for new assay formats to characterize the humoral …
[HTML][HTML] Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1 …
Background Adequate response to the SARS-CoV-2 vaccine represents an important
treatment goal in caring for patients with multiple sclerosis (MS) during the ongoing COVID-19 …
treatment goal in caring for patients with multiple sclerosis (MS) during the ongoing COVID-19 …